368 related articles for article (PubMed ID: 18574763)
41. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
Iłzecka J
Scand J Clin Lab Invest; 2007; 67(3):264-9. PubMed ID: 17454840
[TBL] [Abstract][Full Text] [Related]
42. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
[TBL] [Abstract][Full Text] [Related]
43. Denaturational stress induces formation of zinc-deficient monomers of Cu,Zn superoxide dismutase: implications for pathogenesis in amyotrophic lateral sclerosis.
Mulligan VK; Kerman A; Ho S; Chakrabartty A
J Mol Biol; 2008 Nov; 383(2):424-36. PubMed ID: 18761352
[TBL] [Abstract][Full Text] [Related]
44. A rare Cu/Zn superoxide dismutase mutation causing familial amyotrophic lateral sclerosis with variable age of onset and incomplete penetrance in China.
Zhang H; Zhao H; Lu M; Zhang Y; Wang L; Zhang J; Ma D; Fan D
Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Dec; 6(4):234-8. PubMed ID: 16319027
[TBL] [Abstract][Full Text] [Related]
45. [Amyotrophic lateral sclerosis and superoxide dismutase--a review].
Binzer MN; Gredal O; Brøndum-Nielsen K; Andersen PM
Ugeskr Laeger; 1997 Mar; 159(11):1593-6. PubMed ID: 9092140
[TBL] [Abstract][Full Text] [Related]
46. Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Jiménez-Jiménez FJ; Hernánz A; Medina-Acebrón S; de Bustos F; Zurdo JM; Alonso H; Puertas I; Barcenilla B; Sayed Y; Cabrera-Valdivia F
Acta Neurol Scand; 2005 Feb; 111(2):114-7. PubMed ID: 15644071
[TBL] [Abstract][Full Text] [Related]
47. Familial amyotrophic lateral sclerosis with Gly93Ser mutation in Cu/Zn superoxide dismutase: a clinical and neuropathological study.
Suzuki M; Irie T; Watanabe T; Mikami H; Yamazaki T; Oyanagi K; Ono S
J Neurol Sci; 2008 May; 268(1-2):140-4. PubMed ID: 18191946
[TBL] [Abstract][Full Text] [Related]
48. Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS).
Fang L; Huber-Abel F; Teuchert M; Hendrich C; Dorst J; Schattauer D; Zettlmeissel H; Wlaschek M; Scharffetter-Kochanek K; Tumani H; Ludolph AC; Brettschneider J
J Neurol Sci; 2009 Oct; 285(1-2):62-6. PubMed ID: 19523650
[TBL] [Abstract][Full Text] [Related]
49. SOD1 in cerebral spinal fluid as a pharmacodynamic marker for antisense oligonucleotide therapy.
Winer L; Srinivasan D; Chun S; Lacomis D; Jaffa M; Fagan A; Holtzman DM; Wancewicz E; Bennett CF; Bowser R; Cudkowicz M; Miller TM
JAMA Neurol; 2013 Feb; 70(2):201-7. PubMed ID: 23147550
[TBL] [Abstract][Full Text] [Related]
50. Multiple transcripts of the human Cu,Zn superoxide dismutase gene.
Hirano M; Hung WY; Cole N; Azim AC; Deng HX; Siddique T
Biochem Biophys Res Commun; 2000 Sep; 276(1):52-6. PubMed ID: 11006081
[TBL] [Abstract][Full Text] [Related]
51. Axonal damage markers in cerebrospinal fluid are increased in ALS.
Brettschneider J; Petzold A; Süssmuth SD; Ludolph AC; Tumani H
Neurology; 2006 Mar; 66(6):852-6. PubMed ID: 16567701
[TBL] [Abstract][Full Text] [Related]
52. Development of diabetes in a familial amyotrophic lateral sclerosis patient carrying the I113T SOD1 mutation. Case Report.
Hamasaki H; Takeuchi Y; Masui Y; Ohta Y; Abe K; Yoshino H; Yanai H
Neuro Endocrinol Lett; 2015; 36(5):414-6. PubMed ID: 26707039
[TBL] [Abstract][Full Text] [Related]
53. Pathogenic mechanisms in sporadic amyotrophic lateral sclerosis.
Eisen A; Krieger C
Can J Neurol Sci; 1993 Nov; 20(4):286-96. PubMed ID: 8313244
[TBL] [Abstract][Full Text] [Related]
54. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Shobha K; Vijayalakshmi K; Alladi PA; Nalini A; Sathyaprabha TN; Raju TR
J Neurol Sci; 2007 Mar; 254(1-2):9-16. PubMed ID: 17254611
[TBL] [Abstract][Full Text] [Related]
55. Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC/TOFMS.
Wuolikainen A; Moritz T; Marklund SL; Antti H; Andersen PM
PLoS One; 2011 Apr; 6(4):e17947. PubMed ID: 21483737
[TBL] [Abstract][Full Text] [Related]
56. Cerebrospinal fluid angiogenin level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Clin Croat; 2008 Jun; 47(2):77-9. PubMed ID: 18949901
[TBL] [Abstract][Full Text] [Related]
57. Interleukin-15 and interleukin-12 are elevated in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Rentzos M; Rombos A; Nikolaou C; Zoga M; Zouvelou V; Dimitrakopoulos A; Alexakis T; Tsoutsou A; Samakovli A; Michalopoulou M; Evdokimidis I
Eur Neurol; 2010; 63(5):285-90. PubMed ID: 20407265
[TBL] [Abstract][Full Text] [Related]
58. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes.
Andersen PM; Sims KB; Xin WW; Kiely R; O'Neill G; Ravits J; Pioro E; Harati Y; Brower RD; Levine JS; Heinicke HU; Seltzer W; Boss M; Brown RH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Jun; 4(2):62-73. PubMed ID: 14506936
[TBL] [Abstract][Full Text] [Related]
59. Patterns of levels of biological metals in CSF differ among neurodegenerative diseases.
Hozumi I; Hasegawa T; Honda A; Ozawa K; Hayashi Y; Hashimoto K; Yamada M; Koumura A; Sakurai T; Kimura A; Tanaka Y; Satoh M; Inuzuka T
J Neurol Sci; 2011 Apr; 303(1-2):95-9. PubMed ID: 21292280
[TBL] [Abstract][Full Text] [Related]
60. Superoxide dismutase in CSF from amyotrophic lateral sclerosis patients with and without CuZn-superoxide dismutase mutations.
Jacobsson J; Jonsson PA; Andersen PM; Forsgren L; Marklund SL
Brain; 2001 Jul; 124(Pt 7):1461-6. PubMed ID: 11408340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
